RadNet, Inc. (RDNT)
NASDAQ: RDNT · IEX Real-Time Price · USD
62.00
+1.53 (2.53%)
At close: Jul 19, 2024, 4:00 PM
61.93
-0.07 (-0.11%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

RadNet Revenue

RadNet had revenue of $1.66B in the twelve months ending March 31, 2024, with 12.10% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $431.71M with 10.53% year-over-year growth. In the year 2023, RadNet had annual revenue of $1.62B with 13.05% growth.

Revenue (ttm)
$1.66B
Revenue Growth
+12.10%
P/S Ratio
2.76
Revenue / Employee
$210,591
Employees
7,872
Market Cap
4.58B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.62B186.57M13.05%
Dec 31, 20221.43B114.98M8.74%
Dec 31, 20211.32B243.24M22.69%
Dec 31, 20201.07B-82.34M-7.13%
Dec 31, 20191.15B179.03M18.36%
Dec 31, 2018975.15M52.96M5.74%
Dec 31, 2017922.19M37.65M4.26%
Dec 31, 2016884.54M74.91M9.25%
Dec 31, 2015809.63M92.06M12.83%
Dec 31, 2014717.57M14.58M2.07%
Dec 31, 2013702.99M55.83M8.63%
Dec 31, 2012647.15M62.03M10.60%
Dec 31, 2011585.12M66.46M12.81%
Dec 31, 2010518.66M-8.96M-1.70%
Dec 31, 2009527.62M28.80M5.77%
Dec 31, 2008498.82M75.24M17.76%
Dec 31, 2007423.58M262.57M163.08%
Oct 31, 2006161.01M15.43M10.60%
Oct 31, 2005145.57M8.30M6.04%
Oct 31, 2004137.28M-2.98M-2.13%
Oct 31, 2003140.26M6.18M4.61%
Oct 31, 2002134.08M26.51M24.65%
Oct 31, 2001107.57M19.60M22.28%
Oct 31, 200087.97M15.71M21.74%
Oct 31, 199972.26M13.44M22.84%
Oct 31, 199858.82M-8.20M-12.23%
Oct 31, 199767.02M10.48M18.54%
Oct 31, 199656.54M11.19M24.69%
Oct 31, 199545.34M10.91M31.67%
Oct 31, 199434.44M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PACS Group 3.34B
Alkermes 1.73B
Integer Holdings 1.63B
Haemonetics 1.31B
Inspire Medical Systems 660.91M
Apellis Pharmaceuticals 524.07M
TransMedics Group 296.92M
CRISPR Therapeutics AG 271.71M
Revenue Rankings